companydata.dkcompanydata.dk

FUJIFILM Diosynth Biotechnologies Denmark ApS: Financial statements 2013

CVR: 26060702

Source: annual report 2013, Danish Business Authority

01/01/2013 – 31/12/2013

FUJIFILM Diosynth Biotechnologies Denmark ApS (CVR 26060702) has filed annual accounts for 2013. In 2013, the company reported revenue of DKK 1,054,130,000 and a net result of DKK 102,686,000. The profit margin was 9.7%. Equity in the 2013 report amounted to DKK 3,472,087,000. The solvency ratio was 91.8%. The company had 200 employees in the financial year.

Revenue
DKK 1,054,130,000
Gross Profit
DKK 215,045,000
Profit/Loss
DKK 102,686,000
Equity
DKK 3,472,087,000
Total Assets
DKK 3,784,036,000
Employees
200

Official annual report

View the official annual report directly on the page with a Pro subscription.

Fetch this data via API

Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.

See the API documentation

Events in 2013

FUJIFILM Diosynth Biotechnologies Denmark ApS: The 2012 annual report is outJun 2, 2013

FUJIFILM Diosynth Biotechnologies Denmark ApS has published its annual report for 2012.

About FUJIFILM Diosynth Biotechnologies Denmark ApS

FUJIFILM Diosynth Biotechnologies Denmark ApS is a Danish company of the type Anpartsselskab based in Hillerød, founded in 2001. The company is registered under the industry Fremstilling af farmaceutiske præparater. The company was previously named BIOGEN IDEC (DENMARK) MANUFACTURING ApS and BIOGEN (DENMARK) MANUFACTURING ApS. The management consists of Christian Ørsøe Houborg. The board consists of Toshihisa Iida (chair), Christian Ørsøe Houborg and Masataka Akiyama. The company is owned by FUJIFILM Diosynth Biotechnologies Holdings Denmark ApS. The company has 2,351 employees (2026). In 2026, the company reported revenue of DKK 5,900,744,000 and a net result of DKK -179,945,000 compared with DKK 165,059,000 the year before. Equity in the 2026 report amounted to DKK 6,324,686,000.

Source: annual report 2026, Danish Business Authority